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Abstract
Myeloid differentiation factor 88 (MyD88) and MyD88-adaptor like (Mal)/Toll-interleukin 1 receptor domain containing
adaptor protein (TIRAP) play a critical role in transducing signals downstream of the Toll-like receptor (TLR) family. While
genetic ablation of the TLR4/MyD88 signaling axis in mice leads to pulmonary cell death and oxidative stress culminating in
emphysema, the involvement of Mal, as well as TLR2 which like TLR4 also signals via MyD88 and Mal, in the pathogenesis of
emphysema has not been studied. By employing an in vivo genetic approach, we reveal here that unlike the spontaneous
pulmonary emphysema which developed in Tlr42/2 mice by 6 months of age, the lungs of Tlr22/2 mice showed no
physiological or morphological signs of emphysema. A more detailed comparative analysis of the lungs from these mice
confirmed that elevated oxidative protein carbonylation levels and increased numbers of alveolar cell apoptosis were only
detected in Tlr42/2 mice, along with up-regulation of NADPH oxidase 3 (Nox3) mRNA expression. With respect to Mal, the
architecture of the lungs of Mal2/2 mice was normal. However, despite normal oxidative protein carbonylation levels in the
lungs of emphysema-free Mal2/2 mice, these mice displayed increased levels of apoptosis comparable to those observed in
emphysematous Tlr42/2mice. In conclusion, our data provide in vivo evidence for the non-essential role for TLR2, unlike the
related TLR4, in maintaining the normal architecture of the lung. In addition, we reveal that Mal differentially facilitates the
anti-apoptotic, but not oxidant suppressive, activities of TLR4 in the lung, both of which appear to be essential for TLR4 to
prevent the onset of emphysema.
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Introduction
Emphysema is a major component of the debilitating chronic
obstructive pulmonary disease (COPD), the fifth most common
cause of death world-wide [1]. While cigarette smoke (CS)
exposure is the primary risk factor for COPD, only 10–20% of
heavy smokers develop clinically-significant emphysema, and
approximately 20% of patients with emphysema are non-smokers
[2]. Collectively, these observations suggest that factors intrinsic to
the host (i.e. of genetic origin) are likely to determine an
individual’s susceptibility to emphysema.
Over the last decade, it has become apparent that the interplay
between oxidant/antioxidant imbalances, elevated apoptosis,
excessive protease activity and chronic inflammation are pivotal
to the pathogenesis of emphysema [3–6]. Since CS is a rich source
of oxidants, the molecular mechanisms regulating the balance
between oxidant and anti-oxidant production in the lung have
long been thought to be critical in promoting emphysema. In this
regard, an association between the regulation of oxidative stress by
the innate immune system, and its role in emphysema, has recently
emerged. Specifically, a causal role for TLR4, the prototypical
innate immune pathogen recognition receptor, in the development
of emphysema has been suggested from animal studies whereby
TLR4 deficiency leads to spontaneous emphysema as a result of
excessive oxidant activity [3]. Furthermore, clinical studies have
demonstrated TLR4 polymorphisms and down-regulated TLR4
expression in lung tissues from emphysematous smokers [7,8].
Despite these observations, the downstream signaling pathway(s)
by which TLR4 regulates pulmonary oxidative stress levels and
protects against emphysematous changes in the lung are not fully
understood.
Among the TLR family, TLR2 recognizes the broadest
spectrum of pathogen-associated molecular patterns, including
bacterial peptidoglycans and lipoproteins, whereas TLR4 mediates
responses primarily to lipopolysaccharide from Gram negative
bacteria [9]. All TLRs have a conserved intracytoplasmic Toll/
interleukin (IL)-1 receptor (TIR) domain which is responsible for
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signal transduction. The TIR-domain containing MyD88 adaptor
is essential for signaling by all TLR (and IL-1R) family members,
with the exception of TLR3 [10]. Another adaptor protein closely
related to MyD88 is the TIR domain-containing Mal/TIRAP
[11], which together with MyD88 is essential for the activation of
nuclear factor kappa beta (NF-kB), and p38, extracellular-
regulated kinase (ERK) and c-Jun N-terminal kinase (JNK)
mitogen-activated protein kinase (MAPK) pathways via TLR4
and the related TLR2 [11,12]. Interestingly, both TLR4 and
TLR2 mediated signaling also leads to the rapid activation of the
phosphoinositide-3-kinase (PI3K)/Akt pathway, which is involved
in the regulation of apoptosis and cell growth [13–15]. Although
TLR4 deficiency causes an oxidative imbalance in the lung
leading to emphysema in a MyD88-dependent manner [3], the
role of Mal in emphysema has not been studied. In addition, while
TLR2 has been associated with enhancing airway inflammation
and immunity by facilitating the production of cytokines in COPD
[16–18], the involvement of TLR2 in emphysema development is
not known.
Here we report a differential requirement for TLR2 and TLR4
in protecting against apoptosis and regulating the oxidative
balance in the lung, since Tlr22/2 mice display normal pulmonary
oxidative stress and apoptosis levels, and also fail to develop
emphysema. By contrast, the spontaneous development of
emphysema in Tlr42/2 mice strongly correlated with elevated
oxidative protein carbonylation levels and increased alveolar cell
apoptosis by 6 months of age. Strikingly, although Mal deficiency
in the lungs of mice promoted increased alveolar cell apoptosis
comparable to that observed upon TLR4 deficiency, oxidative
stress levels in Mal2/2 mice were normal, and Mal2/2 mice did
not develop emphysema. Taken together, our findings provide
in vivo evidence for the non-obligate requirement for Mal (unlike
MyD88) specifically by TLR4 in the lung. Furthermore, we
propose that both excessive pulmonary apoptosis and oxidative
stress caused by the absence of TLR4 are required for the
pathogenesis of emphysema.
Materials and Methods
Mice
Mice homozygous null for Tlr4 (Tlr42/2) [19] and Tlr2 (Tlr22/
2) [20] on a C57BL6 background were used with their genetically-
matched wild-type controls. Mice homozygous null for the Mal
gene (Mal2/2) [21] on 129/C57BL6 background were used with
matching background wild-type control mice. Experiments
involving cigarette smoke exposure of mice over 4 days were
performed as described previously [6]. All experiments were fully
approved by the Monash Medical Centre ‘‘A’’ and University of
Melbourne Animal Ethics Committees, and all animals were
housed under specific pathogen-free conditions.
Mouse Tissue Collection
The collection of mouse lungs for stereology, histology and
immunohistochemistry was performed as previously described
[6,22].
Human Lung Samples
Lung tissue from resection surgery for treatment of a solitary
peripheral carcinoma was collected from patients with either no
evidence of emphysema or moderate emphysema, as defined by
pulmonary function tests (gas exchange, FEV1) and histopathology
(Table 1). Lung tissue was collected from individuals, upon formal
written informed consent, with either no evidence of emphysema
(n= 9) or moderate emphysema (n= 14), and then snap frozen in
liquid nitrogen. Studies were approved by the Southern Health
Human Research Ethics Committee.
Stereological Analyses
Lung stereology was performed on methylene blue-stained
tissue sections using computer-assisted newCAST software (version
2.14; Visiopharm, Hørsholm, Denmark) [6,22].
Lung Function Analyses
The assessment of lung function on anesthetized mice was
performed using the flexiVent system (SCIREQ, Montreal,
Canada) [6,22].
Immunohistochemistry and Immunofluorescence
Immunohistochemistry for the detection of apoptosis was
determined by the TUNEL technique using an ApopTag
Peroxidase In Situ Apoptosis Detection kit (Millipore, Billerica,
MA). Stereological techniques were applied to determine the
number of alveolar septal TUNEL-stained cells per 20 fields [22].
Protein Extraction and Immunoblotting
Total protein lysates were prepared from snap-frozen lung tissue
and subjected to immunoblotting for Actin [6,22]. Proteins were
visualized using the Odyssey Infrared Imaging System (LI-COR,
Lincoln, NE) and quantified using the Image J program (nih.gov).
Table 1. Clinical characteristics of patients.
Characteristics Sub-characteristics No emphysema (n=9) Moderate emphysema (n=14)
Sex (patient number) Male 5 8
Female 4 6
Smoking history (Pack years) 53630 52615
Age (years) 6965 7162
Diagnosis Lung cancer (tissues were obtained
from non-cancer area)
Lung cancer (tissues were obtained from
non-cancer area)
FEV1 (% of predicted post)-COPD
status
93.866.7 79.464.5
DLCO (gas transfer, % predicted
post)-emphysema status
75.164.5 51.162.0
Data are expressed as the mean 6 SEM. FEV1, forced expiratory volume in one second. DLCO, diffusing capacity of the lungs for carbon monoxide.
doi:10.1371/journal.pone.0078095.t001
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Oxyblot Assay
Immunoblotting was performed to identify dinitrophenylhydra-
zone derivatives of protein carbonyls using the Protein Oxidation
Kit (Millipore, Billerica, MA). Proteins were visualized by
autoradiography, and the intensity of each lane was quantified
by densitometric scanning and normalized against actin protein
levels.
RNA Isolation and Gene Expression Analysis
Total RNA extraction and the preparation of cDNA for
quantitative RT-PCR (Q-PCR) expression analyses of individual
genes were performed as previously described [6,22]. Sequences
for mouse primers are as follows; Nox2 forward 59-CTTATCA-
CAGCCACAAGCATT-39, Nox2 reverse 59-CACCCATTCA-
CACTGACCTCT-39; Nox3 forward 59-
GCTTGTGGCTGTGATAAGCA-39, Nox3 reverse 59-
CACTGGCTGTACCAAAGGGT-39. Sequences for human
primers are as follows; TLR1 forward 59-CAGTGTCTGGTA-
CACGCATGGT-39, TLR1 reverse 59-
TTTCAAAAACCGTGTCTGTTAAGAGA-39; TLR2 forward
59-GCCTCTCCAAGGAAGAATCC-39, TLR2 reverse 59-
TCCTGTTGTTGGACAGGTCA-39; TLR3 forward 59-
CCTGGTTTGTTAATTGGATTAACGA-39, TLR3 reverse 59-
TGAGGTGGAGTGTTGCAAAGG-39; TLR4 forward 59-
AAGCCGAAAGGTGATTGTTG-39, TLR4 reverse 59-
CTGAGCAGGGTCTTCTCCAC-39; TLR5 forward 59-
TGCCTTGAAGCCTTCAGTTATG-39, TLR5 reverse 59-
CCAACCACCACCATGATGAG-39; TLR6 forward 59-GAA-
GAAGAACAACCCTTTAGGATAGC-39, TLR6 reverse 59-
AGGCAAACAAAATGGAAGCTT-39; MAL forward 59-
TCACGGGGCTAGTTTTGACC-39, MAL reverse 59-
TCTTGGGCTTCTTCAGCAGG-39; 18S forward 59-
CGGCTACCACATCCAAGGAA-39, 18S reverse 59-
GCTGGAATTACCGCGGCT-39.
Statistical Analyses
All statistical analyses were performed using GraphPad Prism
for Windows version 5.0. As data were normally distributed, one-
way ANOVA or student t-test was used to determine differences
between genotypes. A P,0.05 was considered statistically signif-
icant. Data are expressed as the mean 6 SEM.
Results
Genetic Ablation of TLR4, but not TLR2, Leads to
Pulmonary Emphysema in Mice
Since emphysema is caused by Tlr4 gene disruption in mice
[3,23], and emphysema in smokers correlates with impaired TLR4
expression [7,8], we initially investigated the specificity of the
requirement for TLR4 to protect against emphysema by
comparing the lung phenotypes of mice deficient in Tlr4 and the
closely-related Tlr2 gene. Consistent with a previous study [3],
histological evaluation of lung sections from unchallenged Tlr42/2
mice at 6 months of age revealed emphysema as characterized by
enlargement of the distal air spaces and destruction of normal
alveolar architecture (Figure 1A) without any obvious inflamma-
tion (Figure 1B). In addition, the lung volume of Tlr42/2 mice was
significantly increased compared to age matched wild-type control
mice (Figure 1C). By contrast, the histological evaluations and lung
volume measurements of 6 month old Tlr22/2 mice revealed no
airspace enlargement or pulmonary inflammation, and lung
volumes were comparable to wild-type control mice (Figure 1A–
C).
Stereological analyses were next employed to further define
changes in lung morphology associated with emphysematous
alterations [6,22,24]. The Tlr42/2 mice showed significant
increases in the volume fractions of airspace within parenchyma
tissue, as well as per lung, at 6 months of age (Table 2). These
findings are consistent with significant reductions in the volume
fraction and volume of alveolar septal tissue within lung
parenchyma of Tlr42/2 mice at 6 months of age (Table 2), which
reflect a loss of alveolar tissue in lung parenchyma as a result of
alveoli destruction, a hallmark of emphysema. For Tlr22/2 mice,
however, all of the above stereological parameters remained
unchanged and were similar to control wild-type littermates
(Table 2).
To validate the functional relevance of the histology and
stereology data demonstrating emphysematous changes in the
lungs of Tlr42/2 mice, but not Tlr22/2 mice, we next assessed
lung static compliance of mice using the forced oscillatory
technique [6,22,25]. As shown in Figure 1D, the static compliance
was significantly increased in Tlr42/2 mice compared to wild-type
mice, while it remained unchanged in Tlr22/2 mice at 6 months
of age. In addition, the mRNA levels of Tlr4 were comparable in
the lungs of wild-type and Tlr22/2 mice (Figure 1E), thus
confirming that the genetic ablation of Tlr2 had no compensatory
effect on augmenting Tlr4 gene expression in the lung which might
potentially mask detrimental effects of TLR2-deficiency.
Furthermore, these observations that the specific reduction of
Tlr4, but not Tlr2, gene expression in the mouse correlated with
the onset of emphysema were also validated in human disease,
whereby among members of the TLR family, only TLR4 gene
expression was significantly suppressed in human lung tissue from
individuals with emphysema versus emphysema-free controls
(Figure 2). Collectively, these data demonstrate a non-essential
role of TLR2 in emphysema development.
Increased Apoptosis and Oxidative Stress are
Emphysematous Processes Specific to the Lungs of Tlr42/
2, but not Tlr22/2, Mice
Oxidative imbalance is a key process associated with the
development of emphysema in both COPD patients and mouse
disease models, including mice lacking TLR4 [3,26]. In contrast,
there is evidence for a role for TLR2 in activating oxidative stress
in COPD [27,28] and airway inflammation [29]. We therefore
next determined whether the differential role of TLR4 and TLR2
in protecting against the onset of emphysema correlated with
alterations in the oxidant/antioxidant ratio in Tlr42/2 and Tlr22/
2 mice. Immunoblotting for dinitrophenylhydrazone derivatives of
protein carbonyls, a conventional oxidative stress marker gener-
ated by reactive oxygen species, confirmed that there were no
qualitative or quantitative differences in protein carbonyl forma-
tion in the lungs of Tlr22/2 mice. By contrast, increased oxidative
stress was observed in the lungs of Tlr42/2 mice compared to their
wild-type controls (Figure 3A). Previously, intracellular oxidants
such as those derived from the NADPH oxidase (Nox) system have
been implicated in disease states [30,31], and TLR4 deficiency in
mice led to the up-regulation of Nox3 in lungs which correlated
with the emphysema phenotype [3]. Therefore, we also examined
mRNA expression levels of Nox2, the most commonly described
catalytic component of the Nox system, and Nox3 in the lungs of
Tlr42/2 and Tlr22/2 mice. While Nox2 mRNA expression levels
remained unchanged for all genotypes (Figure 3B), Nox3 was
elevated only in the lungs Tlr42/2 mice (Figure 3C).
Another major cellular process associated with the development
of human emphysema and animal models of emphysema,
including TLR4-deficient mice, is apoptosis [3,6,22,32,33].
TLR2 and Mal Do Not Contribute to Lung Integrity
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Similarly, it is found that TLR2 and TLR4 double knockout mice
following the treatment of bleomycin, a non-infectious model of
lung injury, led to increase level of lung cell apoptosis by
suggesting the TLR2/4 together play a protective role in cell
survival to prevent destruction of tissue integrity and allowing for
tissue repair [34,35]. However, it must be noted that in above
animal models, the results regarding the individual roles of TLR2
and TLR4 in protecting lung apoptosis were not studied. We
therefore next compared the levels of apoptosis in the lungs of
Tlr42/2 and Tlr22/26 month old mice by performing TUNEL
staining on lung sections. As shown in Figure 3D, we observed
both qualitative and quantitative (by stereological analysis)
elevation in the numbers of TUNEL-stained cells in lungs of
Tlr42/2 mice with the predominant cell type affected being
alveolar septal cells, while no apoptotic changes were detected in
the lungs of Tlr22/2 mice compared to control mice. Collectively,
the above data indicate that, unlike TLR4, neither oxidative stress
nor apoptosis is affected by the loss of TLR2 signaling in the
mouse lung.
Figure 1. Alveolar air space enlargement, increased lung volume and static compliance in Tlr42/2, but not Tlr22/2, mice. (A)
Representative methylene blue stained cross-sections and (B) representative H&E stained cross-sections of lungs from wild-type (+/+), Tlr42/2 and
Tlr22/2mice aged 6 months. Arrows indicate enlarged airspaces. Scale bars = 100 mm (C) Lung volume per body weight of +/+ and Tlr42/2 and Tlr22/
2 mice. (D) Static compliance of 6 month old +/+, Tlr42/2 and Tlr22/2 mice was assessed by flexiVent lung function analysis. Data are expressed as
mean6 SEM, n = at least 3 mice per genotype. *P,0.05, **P,0.01 versus age-matched +/+mice. (E) Q-PCR expression analyses of Tlr4 was performed
on lung cDNA from 6 month old +/+ and Tlr22/2 mice. Expression data are shown from n= 4 per genotype following normalization for 18S
expression, and are presented as mean 6 SEM from triplicate analysis.
doi:10.1371/journal.pone.0078095.g001
Table 2. Comparative stereological analyses of lungs from
wild-type (+/+), Tlr42/2 and Tlr22/2 mutant mice.
+/+ Tlr42/2 Tlr22/2
Vv (par/lung) (%) 82.3 (60.7) 88.0 (60.3)** 80.9 (61.2)
Vv (airsp/par) (%) 65.5 (61.1) 78.1 (61.0)*** 63.9 (60.7)
V (airsp/lung) (cm3) 48.8 (62.0) 69.2 (61.8)*** 44.9 (63.0)
Vv (sep/par) (%) 26.7 (60.8) 18.4 (60.2)*** 25.4 (60.8)
V (sep/lung) (cm3) 19.9 (60.7) 16.3 (60.5)* 17.8 (60.8)
Sv (sep/par) (1/cm) 667 (67.5) 628 (611) 675 (636)
S (sep/lung) (cm2) 528 (65.9) 553 (610) 540 (66.3)
Data are expressed as the mean 6 SEM. n = at least 5 mice per genotype.
*P,0.05, **P,0.01 and ***P,0.001 versus age-matched +/+ mice. Vv = volume
fraction; par = parenchyma; air = air space; sep = septal tissue; Sv = surface
density; S = surface area.
doi:10.1371/journal.pone.0078095.t002
TLR2 and Mal Do Not Contribute to Lung Integrity
PLOS ONE | www.plosone.org 4 October 2013 | Volume 8 | Issue 10 | e78095
Differential Requirement for Mal in the TLR4-mediated
Protection Against Pulmonary Cell Death and Oxidative
Stress
Since Mal is a key downstream signaling adaptor of both TLR4
and TLR2 [11], the emphysematous and normal appearance of
lungs from Tlr42/2 and Tlr22/2 mice, respectively, suggests that
the pulmonary function(s) of Mal may preferentially align with
either TLR2 or TLR4. Histological evaluation of Mal2/2 mice
revealed morphologically normal alveolar architecture (Figure 4A)
with no apparent inflammation (Figure 4B) at 6 months of age.
Furthermore, both the lung volume and static lung compliance of
Mal2/2 mice were comparable to those of wild-type control mice
(Figure 4C and 4D). In support of these findings, stereological
assessment of Mal2/2 mouse lungs revealed that the volume
fractions of air space and alveolar septal tissue, and surface density
within lung parenchyma, as well as absolute volumes of lung, were
normal at 6 months (Table S1). Notably, there was no significant
change in the expression of Mal in the lungs of emphysematous
Tlr42/2 mice (Figure 4E), and the lack of a role for Mal in the
development of emphysema in human disease was also suggested
by our observation that MAL gene expression was unaltered in
human lung tissue from emphysema and control emphysema-free
individuals (Figure 4F).
In light of the absence of an emphysema phenotype in the lungs
ofMal2/2 mice, unlike the emphysema observed in Tlr42/2 mice,
we next assessed whether the levels of oxidative stress and
apoptosis (both elevated in Tlr42/2 lungs) were also unaltered in
Mal2/2 lungs. Indeed, the lung lysates of Mal2/2 mice revealed
no changes in the levels of dinitrophenylhydrazone derivatives of
protein carbonyls compared to wild-type control mice irrespective
of the absence or presence of cigarette smoke exposure (Figure 5A).
Consistent with the notion that Mal deficiency in the lungs does
not alter oxidative responses, there was no significant alteration in
the gene expression of Nox3 in the lungs ofMal2/2 mice compared
to wild-type control mice (Figure 5B). Interestingly, however,
emphysema-free Mal2/2 mouse lungs showed an elevated level of
apoptosis at 6 months of age (Figure 5C), comparable to that
observed in the lungs of emphysematous Tlr42/2mice (Figure 3D).
We have also examined which apoptotic pathway (extrinsic versus
intrinsic) is associated with the elevated apoptosis in the Mal2/2
mice by performing immune-staining in the lungs of mice for
active-caspase 8 and active-caspase 9. While we could not detect
any caspase-9 staining in the lungs of Mal2/2 (or wild-type) mice,
caspase 8 was significantly increased in Mal2/2 mice (Figure 5D).
Therefore, these data suggest that Mal selectively promotes the
pulmonary anti-apoptotic, but not oxidant suppressive, activities of
TLR4, both of which appear to be essential for TLR4 signaling to
preserve the normal architecture of the lung.
Discussion
Historically, Mal has been assigned an essential role in the
context of facilitating inflammatory signaling responses from
immune cells downstream of TLRs, namely TLR2 and TLR4
[12]. In this paper, we now provide definitive genetic proof that
Mal is not required for the function of TLR4 in protecting against
the onset of emphysema. Since it has also been shown that MyD88
(like TLR4) is required to prevent the onset of emphysema [3],
these observations reveal a differential requirement for Mal and
MyD88 in maintaining normal lung architecture via TLR4
signaling. This finding is analogous to the recently reported non-
essential and essential roles for Mal and MyD88, respectively, in a
TLR2-driven spontaneous gastric tumour mouse model [36]. In
addition, both the onset of emphysema in Tlr42/2 mice and the
TLR2-driven gastric tumour mouse model occurs independent of
hematopoietic-derived immune cells [3,36], which suggests the
essential role for Mal by TLR2 and TLR4 may be more restricted
to immune cells (e.g. macrophages) rather than non-immune (e.g.
lung endothelial, gastric epithelial) cells.
Figure 2. Reduced gene expression of TLR4, but not other TLR family members, in human emphysema tissue. Q-PCR gene expression
analyses of TLRs 1–6 were performed on human lung cDNA from emphysema (Emp) patients (n = 14) or emphysema-free (Control) individuals (n = 9).
Expression data are shown following normalization for 18S expression, and are presented from triplicate analysis as the mean6 SEM. *P,0.05 versus
emphysema-free controls.
doi:10.1371/journal.pone.0078095.g002
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To further explore the requirement for Mal in lung pathology,
we assessed its role in two cellular mechanisms, apoptosis and
oxidative stress, which are associated with emphysema in Tlr42/2
(and MyD882/2) mice. Surprisingly, unlike the dual role of TLR4
and MyD88 in protecting against apoptosis and oxidative stress in
the lung, our data indicated a specific role for Mal in protecting
only against lung alveolar cell death. This observation is supported
by the finding that MyD88 complexed with PI3K is recruited to
TLR4 via Mal for activation [37], an event which is essential to
activate the PI3K/Akt cell survival pathway. In contrast, TLR4
has been reported to mediate pro-apoptotic signaling in airway
epithelial cells of COPD smokers [38] in a different setting (smoke
related) to the spontaneous emphysema observed in Tlr42/2 mice
[3]. While the above studies do not identify the signaling pathways
downstream of TLR4 that either promote or suppress the onset of
apoptosis in the lung, it is conceivable that multiple TLR signaling
pathways are involved (e.g. NF-kB, ERK MAPK, PI3K/Akt), as
has recently been reported for TLR-driven anti-apoptotic
responses during gastric tumourigenesis [39].
Our study also revealed that unlike TLR4 and MyD88 [3], Mal
is not required to balance oxidative stress levels to maintain lung
homeostasis. In this respect, and in contrast to our findings, several
studies have indicated a role for Mal in mediating oxidative stress
in inflammatory disease conditions [40–42], including sepsis-
associated acute lung injury [43]. Similarly, a detrimental role for
MyD88 by activating oxidative stress has been implicated in acute
lung injury [44–46]. As per our earlier discussion, we speculate
that such differences in the role of Mal in emphysema versus
inflammatory disorders are most likely attributed to differences in
the disease-associated cell type(s), as well as the nature of the
upstream TLR stimuli leading to Mal activation. Therefore, it is
possible that TLR4/MyD88 and TLR4/Mal both activate the
classical NF-kB pathway which eventually leads to lung injury
[44], while the pulmonary TLR4/MyD88 axis specifically via the
Figure 3. Increased oxidative stress and pulmonary apoptosis in Tlr42/2, but not Tlr22/2, mice. (A) Protein carbonylation levels were
determined by Oxyblot of lung protein lysates from 6 month old +/+, Tlr42/2 and Tlr22/2 mice. Each lane represents tissue from an individual mouse.
Densitometric quantification of total protein carbonylation in representative samples per genotype was performed and normalized against actin
protein levels present in each sample. Data are presented as the mean fold induction 6 SEM for at least n = 4 per genotype. Q-PCR expression
analyses of (B) Nox2 and (C) Nox3 were performed on lung cDNA from 6 month old mice of the indicated genotypes. Expression data are shown from
at least n = 4 per genotype following normalization for 18S expression, and are presented from triplicate analysis. (D) Representative
photomicrographs showing TUNEL-stained cells in a cross-section of the lungs from the indicated genotypes at 6 months of age. Stereological
quantification of the percentage of TUNEL-stained cells in the lungs of mice. Data are expressed as mean 6 SEM, n = at least 3 mice per genotype.
*P,0.05, **P,0.01 versus age-matched +/+ mice.
doi:10.1371/journal.pone.0078095.g003
TLR2 and Mal Do Not Contribute to Lung Integrity
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Nox system regulates oxidative stress levels to maintain lung
homeostasis [3].
Another key finding of our study was the in vivo evidence that
TLR2 (unlike TLR4) is not required to maintain the structural
integrity of the lung. The role of TLR2 in the disease pathogenesis
of COPD patients is controversial. For instance, it has been shown
that some TLR2 polymorphisms augment the severity of COPD
as a result of a decline in lung function and increased
inflammatory cell numbers [47]. The expression levels of TLR2
in stable COPD patients and healthy smokers decreased signifi-
cantly, and the down-regulation of TLR2 is associated with
reduced lung function parameters [48]. On the other hand, the
expression of TLR2 is up-regulated in peripheral blood monocytes
harvested from COPD patients, either when clinically stable or
during an exacerbation of the disease, as compared to never
smokers or smokers with normal lung function. In addition, no
significant association of TLR2 polymorphisms with either the
onset or the course of COPD has been reported [49], and no
alterations in TLR2 gene expression has been observed in the nasal
epithelium of smokers compared with non-smoking controls [50].
We also point out that it is now emerging, albeit from limited
in vitro studies involving macrophages, that TLR2-induced activa-
tion of NF-kB and MAPK signaling is mainly reliant on MyD88,
while Mal is primarily required for the TLR2-dependent
activation of these signaling cascades in response to low ligand
concentrations [14,15,51,52]. A differential requirement for Mal
in TLR2 signaling also extends to activation of the PI3K/Akt
pathway, where signaling through TLR2/6, but not TLR1/2
heterodimers, requires Mal [14,15,51,52]. We therefore propose
that the reason Tlr42/2 mice develop emphysema while Tlr22/2
mice do not may be attributable, at least in part, to qualitative and
quantitative differences in the TLR2 and TLR4 ligands in the lung
(currently unknown) which are required to activate TLR4 to
protect against the onset of emphysema.
In conclusion, our current study supports a differential
requirement for Mal and MyD88 in TLR4-mediated emphysema,
whereby Mal selectively promotes the pulmonary anti-apoptotic,
but not oxidant suppressive, activities of TLR4, both of which
appear to be essential for TLR4 signaling to preserve the normal
architecture of the lung. Therefore, elucidating the biological
Figure 4. No changes in the emphysematous parameters in Mal2/2 mice. (A) Representative methylene blue stained cross-sections and (B)
representative H&E stained cross-sections of lungs from Mal+/+ (+/+) and Mal2/2 mice aged 6 months. Scale bars = 100 mm (C) Lung volume per body
weight of +/+ and Mal2/2 mice (D) Static compliance of 6 month old +/+ and Mal2/2 mice was assessed by flexiVent lung function analysis. Data are
expressed as mean 6 SEM, n = at least 3 mice per genotype. *P,0.05 versus age-matched +/+ mice. (E) Q-PCR expression analyses of Mal was
performed on lung cDNA from 6 month old +/+ and Tlr42/2mice. Expression data are shown from n= 4 per genotype per following normalization for
18S expression, and are presented as mean6 SEM from triplicate analysis. (F) Q-PCR expression analysis of MAL was performed on human lung cDNA
from emphysema (Emp) patients (n = 14) or emphysema-free (Ctl) individuals (n = 9). Expression data are shown following normalization for 18S
expression, and are presented from triplicate analysis as the mean 6 SEM.
doi:10.1371/journal.pone.0078095.g004
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consequences of TLR4/MyD88 and TLR4/Mal pulmonary
signaling may provide novel therapeutic strategies to protect the
lung from oxidant induced injury (re-perfusion injury, ozone and
other pollutant) without compromising immunity and mucosal
host defence. It is also worth noting that although Mal2/2 mice
have no evidence of emphysema, the elevated spontaneous
apoptosis observed in Mal-deficient mouse lungs suggests that
Mal may be a critical determinant in emphysema disease severity
in response to bacterial infections which can cause severe disease
exacerbation as seen in COPD/emphysema patients. Indeed, Mal
is the most polymorphic of the TLR signaling adaptors, and
several studies have indicated that single nucleotide polymor-
phisms in the gene for Mal (TIRAP) are associated with increased
susceptibility to bacterial infections, including those (e.g. Hae-
mophilus influenzae) related to lung disease [53,54] Accordingly, it
is conceivable that increased apoptosis caused by Mal deficiency in
the lungs may predispose to emphysematous changes upon
exposure to an additional pathological insult, such as bacterial
infection with lung pathogens, which is worthy of future
investigation. Finally, this study also provides first in vivo evidence
for the dispensable role of TLR2, unlike its related TLR family
member TLR4, in preventing emphysematous changes within the
lung. It will now be of great interest to determine the downstream
molecular pathways associated with apoptosis and oxidative stress
in maintaining lung homeostasis in TLR4-driven innate immunity,
as well as the identity of TLR4-specific ligands involved in these
cellular processes.
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Figure 5. Altered lung cell apoptosis, but not oxidative stress, inMal2/2mice. (A) Protein carbonylation levels were determined by Oxyblot
of lung protein lysates from +/+ and Mal2/2mice that were either exposed to air or were exposed to cigarette smoke for 4 days. Each lane represents
tissue from an individual mouse. Densitometric quantification of total protein carbonylation in representative samples per genotype was performed
and normalized against actin protein levels present in each sample. Data are presented as the mean fold induction 6 SEM for at least n = 4 per
genotype. (B) Q-PCR expression analyses of Nox3 was performed on lung cDNA from 6 month old +/+ and Mal2/2 mice. Expression data are shown
from n= 4 per genotype following normalization for 18S expression, and are presented as mean 6 SEM from triplicate analysis. (C) Representative
photomicrographs showing TUNEL-stained cells and (D) active-caspase 8 (Cas8)-stained cells in a cross-section of the lungs from the indicated
genotypes at 6 months of age. Graphs depict stereological quantification of the percentage of TUNEL and Cas8-stained cells in the lungs of mice.
Data are expressed as mean 6 SEM, n = at least 3 mice per genotype. **P,0.01, versus age-matched +/+ mice.
doi:10.1371/journal.pone.0078095.g005
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